Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
RDW
3 Unpopular Stocks We Find Risky StockStory - Sun Jun 7, 11:40PM CDT

3 Unpopular Stocks We Find Risky

RDW : 15.75 (-15.19%)
BFH : 94.22 (+3.06%)
JAZZ : 229.19 (-1.23%)
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia PR Newswire - Thu Jun 4, 6:45AM CDT

Twenty-one abstracts, including 11 late-breaking abstracts, underscore Jazz's unwavering commitment to advancing the treatment of narcolepsy and idiopathic hypersomnia

JAZZ : 229.19 (-1.23%)
OMCL
3 Healthcare Stocks We Think Twice About StockStory - Thu May 28, 11:34PM CDT

3 Healthcare Stocks We Think Twice About

OMCL : 40.69 (-3.00%)
PNTG : 32.77 (+4.43%)
JAZZ : 229.19 (-1.23%)
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA PR Newswire - Wed May 27, 4:00PM CDT

Expanded safety, subgroup, progression-free survival sensitivity and subsequent therapy analyses further characterize the consistency and durability of outcomes observed with zanidatamab-containing...

JAZZ : 229.19 (-1.23%)
AIT
3 Mid-Cap Stocks We’re Skeptical Of StockStory - Sun May 24, 11:37PM CDT

3 Mid-Cap Stocks We’re Skeptical Of

JAZZ : 229.19 (-1.23%)
AIT : 322.81 (+2.67%)
IEX : 222.14 (+1.62%)
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire - Tue May 12, 3:15PM CDT

DUBLIN , May 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor conferences:

JAZZ : 229.19 (-1.23%)
JAZZ
Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions StockStory - Tue May 12, 12:39AM CDT

Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions

JAZZ : 229.19 (-1.23%)
Desktop and Mobile Trading by rawf8 via Shutterstock
5 Stocks Our Top Technical Strategist is Tracking Now Barchart - Thu May 7, 10:44AM CDT

From the pullback in refining stock PSX to the breakout in AI pick Corning, here’s what John Rowland is watching ahead of Friday’s livestream.

NVDA : 208.19 (-0.22%)
FSLR : 262.19 (-4.79%)
GLW : 173.94 (-7.25%)
PSX : 179.00 (-2.41%)
JAZZ : 229.19 (-1.23%)
SPY : 737.05 (-0.29%)
JOBY : 9.27 (-4.43%)
JAZZ
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why StockStory - Wed May 6, 11:25AM CDT

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

JAZZ : 229.19 (-1.23%)
JAZZ
JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals StockStory - Wed May 6, 12:40AM CDT

JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals

JAZZ : 229.19 (-1.23%)

Barchart Exclusives

Nasdaq Futures Plunge as Tech Selloff Deepens, U.S. Inflation Data in Focus Barchart - 22 minutes ago
June Nasdaq 100 E-Mini futures (NQM26) are down -1.36% this morning as investors continued to trim exposure to the technology sector, with the focus now turning to key U.S. inflation data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.